Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly

BACKGROUND: The aim of this study was to describe the clinical (treatment adherence, metabolic control, hypoglycemia, and macrovascular complications) and economic (resource use and costs) consequences of using a combination of metformin + vildagliptin to treat type 2 diabetes in elderly patients se...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicras-Mainar, Antoni, Navarro-Artieda, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069049/
https://www.ncbi.nlm.nih.gov/pubmed/24970999
http://dx.doi.org/10.2147/DDDT.S65327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069049/
https://www.ncbi.nlm.nih.gov/pubmed/24970999
http://dx.doi.org/10.2147/DDDT.S65327

Ejemplares similares